Last reviewed · How we verify

NCT05928182

El Faro: Addressing Mental Health Inequities Among Latinx Children With ADHD in Durham

Completed NA Last updated 30 July 2024
What this trial tests

NA trial testing El Faro Treatment Intervention in ADHD in 32 participants. Completed in 30 May 2024.

Timeline
10 October 2023
Primary endpoint
30 May 2024
30 May 2024

Quick facts

Lead sponsorDuke University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment32
Start date10 October 2023
Primary completion30 May 2024
Estimated completion30 May 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Duke University

Who can join

Adults 6 to 12, any sex, with ADHD or Psychiatric Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study team members from El Futuro in Durham, North Carolina have created an intervention called El Faro. El Faro helps Latinx families of children with ADHD understand and cope with the stress and difficulties presented by the disorder. We propose to develop a community-engaged research partnership between El Futuro and the Duke ADHD Program that aims to pilot-test an adapted El Faro treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for ADHD

Currently open trials in the same condition.

Other Duke University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05928182.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing